Literature DB >> 27102538

Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).

Elaine M Gutierrez1, Nicole A Seebacher1, Laila Arzuman1, Zaklina Kovacevic1, Darius J R Lane1, Vera Richardson1, Angelica M Merlot1, Hiu Lok1, Danuta S Kalinowski1, Sumit Sahni1, Patric J Jansson2, Des R Richardson3.   

Abstract

The potent and selective anti-tumor agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), localizes in lysosomes and forms cytotoxic copper complexes that generate reactive oxygen species (ROS), resulting in lysosomal membrane permeabilization (LMP) and cell death. Herein, the role of lysosomal membrane stability in the anti-tumor activity of Dp44mT was investigated. Studies were performed using molecules that protect lysosomal membranes against Dp44mT-induced LMP, namely heat shock protein 70 (HSP70) and cholesterol. Up-regulation or silencing of HSP70 expression did not affect Dp44mT-induced LMP in MCF7 cells. In contrast, cholesterol accumulation in lysosomes induced by the well characterized cholesterol transport inhibitor, 3-β-[2-(diethyl-amino)ethoxy]androst-5-en-17-one (U18666A), inhibited Dp44mT-induced LMP and markedly and significantly (p<0.001) reduced the ability of Dp44mT to inhibit cancer cell proliferation (i.e., increased the IC(50)) by 140-fold. On the other hand, cholesterol extraction using methyl-β-cyclodextrin enhanced Dp44mT-induced LMP and significantly (p<0.01) increased its anti-proliferative activity. The protective effect of U18666A in increasing lysosomal cholesterol and preventing the cytotoxic activity of Dp44mT was not due to induced autophagy. Instead, U18666A was found to decrease lysosomal turnover, resulting in autophagosome accumulation. Moreover, preincubation with U18666A did not prevent the ability of Dp44mT to induce autophagosome synthesis, indicating that autophagic initiation via Dp44mT occurs independently of LMP. These studies demonstrate the significance of lysosomal membrane stability in relation to the ability of Dp44mT to execute tumor cell death and overcome pro-survival autophagy. Hence, lysosomal-dependent cell death induced by Dp44mT serves as an important anti-tumor strategy. These results are important for comprehensively understanding the mechanism of action of Dp44mT.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Dp44mT; Lysosomal membrane permeabilization; Lysosomes

Mesh:

Substances:

Year:  2016        PMID: 27102538     DOI: 10.1016/j.bbamcr.2016.04.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents.

Authors:  Yalan Guo; Yujie Wang; Haihong Li; Ke Wang; Qi Wan; Jia Li; Yubo Zhou; Ying Chen
Journal:  ACS Med Chem Lett       Date:  2018-04-20       Impact factor: 4.345

2.  Unravelling the antitumoral potential of novel bis(thiosemicarbazonato) Zn(II) complexes: structural and cellular studies.

Authors:  Elisa Palma; Hugo M Botelho; Goreti Ribeiro Morais; Inês Rodrigues; Isabel Cordeiro Santos; Maria Paula Cabral Campello; Paula Raposinho; Ana Belchior; Susana Sousa Gomes; Maria Fátima Araújo; Isabel Correia; Nadia Ribeiro; Sofia Gama; Filipa Mendes; António Paulo
Journal:  J Biol Inorg Chem       Date:  2018-11-24       Impact factor: 3.358

3.  Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines.

Authors:  Azmat Ali Khan; Rehan Ahmad; Amer M Alanazi; Nawaf Alsaif; Maha Abdullah; Tanveer A Wani; Mashooq A Bhat
Journal:  Saudi Pharm J       Date:  2022-03-31       Impact factor: 4.562

4.  A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC.

Authors:  Nicole A Seebacher; Des R Richardson; Patric J Jansson
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

5.  The role of oxidative stress in activity of anticancer thiosemicarbazones.

Authors:  Katarzyna Malarz; Anna Mrozek-Wilczkiewicz; Maciej Serda; Marta Rejmund; Jaroslaw Polanski; Robert Musiol
Journal:  Oncotarget       Date:  2018-04-03

6.  Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.

Authors:  Vadim Le Joncour; Pauliina Filppu; Maija Hyvönen; Minna Holopainen; S Pauliina Turunen; Harri Sihto; Isabel Burghardt; Heikki Joensuu; Olli Tynninen; Juha Jääskeläinen; Michael Weller; Kaisa Lehti; Reijo Käkelä; Pirjo Laakkonen
Journal:  EMBO Mol Med       Date:  2019-06       Impact factor: 12.137

Review 7.  Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers.

Authors:  Yomna S Abd El-Aziz; Andrew J Spillane; Patric J Jansson; Sumit Sahni
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

8.  The Interplay of Ascorbic Acid with Quinones-Chelators-Influence on Lipid Peroxidation: Insight into Anticancer Activity.

Authors:  Olga Yu Selyutina; Polina A Kononova; Vladimir E Koshman; Lidiya G Fedenok; Nikolay E Polyakov
Journal:  Antioxidants (Basel)       Date:  2022-02-13

Review 9.  Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.

Authors:  Viktor A Timoshnikov; Olga Yu Selyutina; Nikolay E Polyakov; Victoria Didichenko; George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

10.  The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms.

Authors:  Zhu-Ling Guo; Des R Richardson; Danuta S Kalinowski; Zaklina Kovacevic; Kian Cheng Tan-Un; Godfrey Chi-Fung Chan
Journal:  J Hematol Oncol       Date:  2016-09-27       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.